Meanwhile, pharmaceutical stocks continued their upward march, led by gains in Haleon, Abbott Laboratories and ...
Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
CNW/ - GSK announced today that Health Canada has approved Ojjaara (momelotinib) for the treatment of splenomegaly and/or ...
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, has announced it is pledging $7.8 million to the ‘Fund our Futures’ campaign led by ...
In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...
Hosted on MSN10h
GSK lowered to hold by Jefferies, valuation disconnect citedJefferies lowered GSK (NYSE:GSK) to hold, citing a valuation disconnect between fundamentals and price. Jefferies said it ...
€400 million upfront payment from restructured GSK collaboration reflected in financials, cash position increased to €551 million; expected cash runway re-affirmed into 2028 CVGBM Phase 1 glioblastoma ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback